- Dr. Rosenthal an expert on topical issues of mental health, general medical care and well-being.
- Early Drug Development (EDD) and Experimental Medicine
- Leaders in strategies to accelerate global drug development, including ethnobridging studies
Murray Rosenthal, D.O., is a psychiatrist who has a unique blend of educational and training experiences is a strong asset to clinical research.
Dr. Rosenthal worked with a number of specialty medical units including the head trauma and stroke unit, cardiac rehabilitation, and transplantation programs.
He also served as the medical director of the inpatient eating disorders unit (Balance Program).
He helped direct the development of a pilot mental health program and regularly met with physician boards to assist with their understanding of the impact of mental health issues in their specialties.
The broad base of practical clinical experience represented by Dr. Rosenthal is best exemplified by his regular appearance on local television and radio.
He is often sought after as an expert on topical issues of mental health, general medical care and well-being.
As the Senior Medical Director and CEO of Clinical Trials, Dr. Rosenthal oversees 60 new clinical trials a year in all areas of CNS research.
He is regularly called upon by industry leaders for both in-house development and presentations at national meetings. He maintains a hands-on style and is actively engaged in staff and physician education at all levels.
He has also developed and implemented programs in Placebo Response and PANSS Training that are already showing results for sponsors.
Dr. Rosenthal actively works with numerous pharmaceutical companies on study design and novel applications using his practical experiences as a clinician.